Adamia, Sophia
Name: | Adamia, Sophia |
Email: | |
Organization: | |
Webpage: | none |
Interest(s): | |
Publications: |
1. | S. Adamia, M. Bar-Natan, B. Haibe-Kains, P. Pilarski, C. Bach, S. Pevzner, T. Calimeri, H. Avet-Loiseau, L. Lode, S. Verselis, E. Fox, I. Galinsky, S. Mathews, I. Dagogo-Jack, M. Wadleigh, D. Steensma, G. Motyckova, D. Deangelo, J. Quackenbush, D. Tenen, R. Stone, J. Griffin. "NOTCH2 and FLT3 gene mis-splicing are common events in patients with acute myeloid leukemia (AML): new potential targets in AML". Blood, 123(18), pp 2816–2825, May 2014. |
2. | S. Adamia, B. Haibe-Kains, P. Pilarski, M. Bar-Natan, S. Pevzner, H. Avet-Loiseau, L. Lode, S. Verselis, E. Fox, J. Burke, I. Galinsky, I. Dagogo-Jack, M. Wadleigh, D. Steensma, G. Motyckova, D. Deangelo, J. Quackenbush, R. Stone, J. Griffin. "A Genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets". Clinical Cancer Research (CCR), 20(5), pp 1135-1145, March 2014. |
3. | S. Adamia, P. Pilarski, M. Bar-Natan, R. Stone, J. Griffin. "Alternative splicing in chronic myeloid leukemia (CML): a novel therapeutic target?". Current Cancer Drug Targets, 13(7), pp 735–748, September 2013. |
4. | S. Adamia, P. Pilarski, A. Belch, L. Pilarski. "Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets". Current Cancer Drug Targets, 13(4), pp 347–361, May 2013. |
Author List